Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: A prospective pilot study

Journal of Pediatric Gastroenterology and Nutrition

Volumn 46, Issue 4, 2008, Pages 386-391

  Martín De Carpi, Javier ^a   Vilar, Pere ^a   Prieto, Gerardo ^b   Novo, María Dolores García ^c   Ribes, Carmen ^d   Varea, Vicente ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Crohn disease; Granulocyte monocyte adsorption apheresis; Paediatric inflam matory bowel disease; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BUDESONIDE; IMMUNOMODULATING AGENT; INFLIXIMAB; MESALAZINE; PREDNISOLONE; STEROID; VANCOMYCIN;

ABDOMINAL PAIN; ACUTE GASTROENTERITIS; ADOLESCENT; ADSORPTION; ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTAPHERESIS; DIZZINESS; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; ENTERITIS; FEMALE; GRANULOCYTE; HUMAN; HYPOTENSION; IMMUNOMODULATION; MALE; MEDICAL INSTRUMENTATION; MONOCYTE; PATIENT SAFETY; PRIORITY JOURNAL; RED MAN SYNDROME; REMISSION; SCHOOL CHILD; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADOLESCENT; ADSORPTION; ANTI-INFLAMMATORY AGENTS; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; DRUG RESISTANCE; FEMALE; GRANULOCYTES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKAPHERESIS; MALE; MONOCYTES; PILOT PROJECTS; PROSPECTIVE STUDIES; REMISSION INDUCTION; SAFETY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 41449088341     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31815604e5     Document Type: Article

References (24)

1. Hanai H, Watanabe F, Takeuchi K, et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003;1:28-35.
2. Hanai H, Watanabe F, Saniabadi A, et al. Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Dig Dis Sci 2002;47:2349-53.
3. Naganuma M, Funakoshi S, Sakuraba A, et al. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis. Inflamm Bowel Dis 2004;10:251-7.
4. Domènech E, Hinojosa J, Esteve-Comas M, et al. Granulocyteapheresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Aliment Pharmacol Ther 2004;20:1347-52.
5. Fukuda Y, Matsui T, Kanhe K, et al. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study. J Gastroenterol 2004;39:1158-64.
6. Kusaka T, Fukunaga K, Ohnishi K, et al. Adsorptive monocyte- granulocytapheresis (M-GCAP) for refractory Crohn's disease. J Clin Apher 2004;19:168-73.
7. Shimoyama T, Sawada K, Hiwatashi N, et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 2001;16:1-9.
8. Rembaken BJ, Newbould HE, Richards SA, et al. Granulocyte apheresis in inflammatory bowel disease: possible mechanism of effect. Ther Apher 1998;2:39-46.
9. Kashigawi N, Sugimura K, Kowiwai H, et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002;47:1334-41.
10. Ramlow W, Emmrich J, Ahrenholz P, et al. In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy volunteers. J Clin Apheresis 2005;20:72-80.
11. Takeda Y, Shiobara N, Saniabadi AR, et al. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3, and beta2 integrin. Inflamm Res 2004;53:277-83.
12. Tomomasa T, Kobayashi A, Kaneko H, et al. Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis. Dig Dis Sci 2003;48:750-4.
13. Kawasaki Y, Suzuki J, Suzuki S, et al. Leukocytapheresis with leukocyte removal filter for severe ulcerative colitis in childhood. J Pediatr Gastroenterol Nutr 2004;39:422-5.
14. Mori K, Yoshihara T, Ando T, et al. Cytapheresis therapy for ulcerative colitis in three pediatric patients. J Pediatr Gastroenterol Nutr 2004;39:549-51.
15. Ikeda H, Ishumaru Y, Takayasu H, et al. Efficacy of granulocyte apheresis in pediatric patients with ulcerative colitis: a pilot study. J Pediatr Gastroenterol Nutr 2006;43:592-6.
16. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. BMJ 1954;4883:375-8.
17. Kundhal PS, Critch JN, Zachos M, et al. Pediatric Crohn Disease Activity Index: responsive to short-term change. J Pediatr Gastroenterol Nutr 2003;36:83-9.
18. Bernal I, Manosa M, Domènech E, et al. Predictors of clinical response to systemic steroids in active ulcerative colitis. Dig Dis Sci 2006;51:1434-8.
19. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. BMJ 1964;1:89-92.
20. Saverymuttu SH, Camilleri M, Rees H, et al. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and faecal indium 111-granulocyte excretion. Gastroenterology 1986;90:1121-88.
21. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262-7.
22. Hanai H, Watanabe F, Yamada M, et al. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis. Digestion 2004;70:36-44.
23. Hanai H. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol 2006;12:7568-77.
24. Suzuki Y, Yoshimura N, Saniabadi AR, et al. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 2004;49:565-71.